ADVISORY BOARDS

Head of Scientific Advisory Board — Susan L. Kelley, M.D.

1. Oncology

Ovarian Cancer

Angeles Alvarez Secord, M.D., Duke University
Rebecca C. Arend, M.D., University of Alabama at Birmingham
Robert A. Burger, M.D., University of Pennsylvania
Thomas Herzog, M.D., University of Cincinnati Cancer Institute
Jonathan A. Ledermann, M.D., UCL Cancer Institute

Bradley J. Monk, M.D., FACS, FACOG, Univ. of Arizona& Creighton Univ.
Kathleen Moore, M.D., University of Oklahoma Health Sciences Center
Richard T. Penson, M.D., MRCP, Massachusetts General Hospital
Ronnie Shapira-Frommer, M.D., Sheba Medical Center
Krishnansu S. Tewari, M.D., University of California

Glioblastoma (GBM) 

Andrew J. Brenner, M.D., Ph.D., The University of Texas Health Science Center
Nicholas Butowski, M.D., University of California
Timothy Cloughesy, M.D., UCLA
Patrick Y. Wen, M.D., Dana-Farber Cancer Institute

Thyroid Cancer

Keith Bible, M.D., Ph.D., Mayo Clinic Cancer Center

2. Additional Experts

Ronald Goldblum, M.D., Carlsbad Pharmaceutical Consulting, Inc.
Bonnie Goldman, M.D., Goldman Consulting, LLC
Melanie Hartsough, Ph.D.
Rachel W. Humphrey, M.D.
Iftekhar Mahmood, Ph.D.

David Smolin, Ph.D.